Shoreline Biome, the developer of the Titan-1TM microbiome research, discovery, and testing platform, has changed its name to Intus Biosciences.
Intus—a Latin word for “inside”— reflects the company’s focus on making advances in health and wellbeing by working inside the bacterial microbiome. The change marks Intus Biosciences’ strategic transformation from supplying research tools to providing complete data-driven solutions for microbiome discovery and understanding.
The company’s unique and scalable Titan-1TM platform powers “sample to answer” services for pharmaceutical, diagnostic, and research partners, and supports cutting-edge testing for commercial laboratories to identify and track bacteria in unprecedented detail.